Current Study: B 7

Study: B 7

Investigator: Thomas Marbury, MD
Research Study: Liver Studies


• To determine how the investigational drug is broken down and removed from the body in volunteers with liver impairment when compared to volunteers with normal liver function
• Information regarding safety and side effects that may occur will also be collected
• This study is for research purposes only and is not intended to treat your liver disease

Method of Administration: Single oral dose of study medication

To qualify:

• 18 to 80 years old
• Diagnosed with liver disease or liver damage
• May have cirrhosis due to Hepatitis C, fatty liver disease, including NASH, or history of alcohol-related liver disease
• May be taking medicines such as spironolactone, furosemide, lactulose, and/or Xifaxan®
• May have fluid in your abdomen or previous encephalopathy (brain condition that causes irritability, sleepiness, or trouble sleeping)

• 12 consecutive days and 11 nights in our research facility

5055 South Orange Avenue, Orlando, FL 32809

Qualified participants will receive study medication, study related physical exams and laboratory tests

Compensation: Qualified study participants will be compensated up to $3,500 for time and travel

Whom to Contact:  Recruitment Department: 407-240-7876

Orlando Clinical Research Center
5055 South Orange Avenue
Orlando, FL 32809

Recruiting Number: 407.240.7878

Apply now for Study: B 7